title: CCR8 signaling influences Toll-like receptor 4 responses in human macrophages in inflammatory diseases.
abstract: CCR8 immunity is generally associated with Th2 responses in allergic diseases. In this study, we demonstrate for the first time a pronounced attenuated influx of macrophages in ovalbumin (OVA)-challenged CCR8 knockout mice. To explore whether macrophages in human inflamed lung tissue also were CCR8 positive, human lung tissue from patients with chronic obstructive pulmonary disease (COPD) was evaluated. Indeed, CCR8 expression was pronounced in invading monocytes/macrophages from lungs of patients with Global Initiative for Obstructive Lung Disease (GOLD) stage IV COPD. Given this expression pattern, the functional role of CCR8 on human macrophages was evaluated in vitro. Human peripheral blood monocytes expressed low levels of CCR8, while macrophage colony-stimulating factor (M-CSF)-derived human macrophages expressed significantly elevated surface levels of CCR8. Importantly, CCL1 directly regulated the expression of CD18 and CD49b and hence influenced the adhesion capacity of human macrophages. CCL1 drives chemotaxis in M-CSF-derived macrophages, and this could be completely inhibited by lipopolysaccharide (LPS). Whereas both CCL1 and LPS monotreatment inhibited spontaneous superoxide release in macrophages, CCL1 significantly induced superoxide release in the presence of LPS in a dose-dependent manner. Finally, CCL1 induced production of proinflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) and could inhibit LPS-induced cytokine production in a dose-dependent manner. Our data demonstrate, for the first time, the presence of CCR8 on inflammatory macrophages in human COPD lung tissue. Importantly, the functional data from human macrophages suggest a potential cross talk between the CCR8 and the Toll-like receptor 4 (TLR4) pathways, both of which are present in COPD patients.
authors: AstraZeneca R&D, Lund S-221 87, Sweden.
authors: Martina Kvist
authors: MK
authors: Reimer
authors: Charlotte
authors: C
authors: Brange
authors: Alexander
authors: A
authors: Rosendahl
mesh_terms: D000818:Animals; D018821:CD18 Antigens / Q000096:biosynthesis; D054402:Chemokine CCL1 / Q000276:immunology / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D039421:Integrin alpha2 / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000276:immunology; D016173:Macrophage Colony-Stimulating Factor / Q000276:immunology / Q000378:metabolism; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D029424:Pulmonary Disease, Chronic Obstructive / Q000276:immunology*; D054401:Receptors, CCR8 / Q000276:immunology* / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000276:immunology* / Q000378:metabolism
chemical_list: C065971:CCL1 protein, human; C103330:CCR8 protein, human; D018821:CD18 Antigens; C489319:Ccr8 protein, mouse; D054402:Chemokine CCL1; D039421:Integrin alpha2; D008070:Lipopolysaccharides; D054401:Receptors, CCR8; C495345:TLR4 protein, human; C493487:Tlr4 protein, mouse; D051197:Toll-Like Receptor 4; D013481:Superoxides; D016173:Macrophage Colony-Stimulating Factor